Status:
COMPLETED
Assessing Efficacy of Neuropsychiatric Assessment and Treatment Protocols in Huntington's Disease Patients
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
Teva Pharmaceuticals USA
Conditions:
Huntington Disease
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Phase A: Recruit 50 patients with HD, and their caregivers, to complete a neuropsychiatric and quality of life battery of scales at baseline. Have these 50 patients complete a formal psychiatric asses...
Detailed Description
As presented to Phase A (control) patient participant: "If you are in this study, you will be asked to answer a series of online surveys assessing your psychiatric symptoms and quality of life in the...
Eligibility Criteria
Inclusion
- Patient participants:
- Diagnosed with HD, either through genetic testing or neurologist's clinical diagnosis
- Patient has at least 1 neuropsychiatric symptom, as reported by their HD provider
- 21 and older will be included, as symptoms of Juvenile HD (in patients 20 years old or less) can present differently
- Presence of an eligible caregiver who can also participate in the study with them because several of the study measures require caregiver report
- Caregivers:
- 18 years or older
- A caregiver will be defined as someone who lives with or has at least weekly contact with the HD patient
Exclusion
- Patient participants:
- 20 years old or younger
- Greater than moderate impairment on dementia screening
- Lack of a caregiver to provide collateral information and complete caregiver assessments will also be excluded
- Caregivers:
- Younger than 18 years old and/or have less than weekly contact with the HD patient
- Clinical impression of incompetency to answer survey questions as determined by the Jessie Sellers, Nurse Practitioner, or the neurologist caring for the HD patient, then he or she will not be eligible to participate.
Key Trial Info
Start Date :
November 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 10 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03417583
Start Date
November 9 2018
End Date
October 10 2023
Last Update
November 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt Medical Center
Nashville, Tennessee, United States, 37232